Tag: Stryker Neurovascular
Stryker completes acquisition of Cerus Endovascular
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...
“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
Getting it right the first time: Commit to a first-pass effect...
Advertorial
While the treatment paradigm for stroke continues to evolve, even a quick review of the current literature will point to how complete reperfusion...
Stryker gains US FDA premarket approval for Neuroform Atlas stent system
Stryker has announced the premarket approval (PMA) of the Neuroform Atlas stent system by the US Food and Drug Administration (FDA).
Neuroform Atlas—according to the...
Stryker launches next-generation flow diverter for treatment of brain aneurysms
Stryker has announced the availability of the Surpass Evolve flow diverter following CE-mark approval in March. Surpass Evolve is Stryker’s latest entrant into the...
Greater obliteration and less in-stent stenosis after ATLAS stent coiling as...
According to research published in the Journal of NeuroIntervential Surgery, Atlas stent-assisted coiling outperformed LVIS Jr in terms of greater obliteration rates and lower...
FDA gives HDE approval for Neuroform Atlas to treat wide neck...
The US Food and Drug Administration has approved the Neuroform Atlas Stent System (Stryker) for marketing under a humanitarian device exemption (HDE). The device...
Coiling of <5mm aneurysms safe and efficacious in Target registry sub-analysis
Based on a sub-analysis of the data from the prospective Target aneurysm multicentre registry, the coiling of aneurysms <5mm in size with Target coils...
DAWN of a new era: Time to save brain may be...
The much-anticipated results from the DAWN trial were finally revealed at the European Stroke Organisation Conference (ESOC; 16–18 May, Prague, Czech Republic) strongly indicating...
Enrolment stopped early in DAWN trial
An early end to patient enrolment in the DAWN trial has been activated following a pre-planned interim analysis of the data from the first...
US FDA broadens treatment indication for Stryker’s Trevo device
The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...
Thousandth patient enrolled in Stryker’s Trevo Retriever Registry
Data from the first 500 patients enrolled in the Trevo Registry were presented at the European Stroke Organisation Conference (ESOC; 10-12 May, Barcelona, Spain)...
“Push & Fluff” deployment proves better for radiopaque retriever
While the traditional unsheathing technique for the deployment of stent retrievers has proved successful in clinical use, in their experience, Raul Gomes Nogueira (Emory...
Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular...
Diogo Haussen and colleagues (Emory University School of Medicine, Atlanta, USA) report that their initial data suggest that treatment of distal cerebrovascular occlusions with...
Foreign body retrieval could be new indication for Trevo ProVue in...
A case report has described the novel use of a stent for the removal of a foreign body from the cerebrovascular system.
Stryker launches Trevo XP ProVue retrieval system
Stryker has launched the Trevo XP ProVue retrieval system, a second generation fully visible stent retriever to treat acute ischaemic stroke.
